136 related articles for article (PubMed ID: 28740213)
1. Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.
Herzog R; Kuster L; Becker J; Gluexam T; Pils D; Spittler A; Bhasin MK; Alper SL; Vychytil A; Aufricht C; Kratochwill K
Sci Rep; 2017 Jul; 7(1):6229. PubMed ID: 28740213
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
Vychytil A; Herzog R; Probst P; Ribitsch W; Lhotta K; Machold-Fabrizii V; Wiesholzer M; Kaufmann M; Salmhofer H; Windpessl M; Rosenkranz AR; Oberbauer R; König F; Kratochwill K; Aufricht C
Kidney Int; 2018 Dec; 94(6):1227-1237. PubMed ID: 30360960
[TBL] [Abstract][Full Text] [Related]
3. Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.
Kratochwill K; Boehm M; Herzog R; Gruber K; Lichtenauer AM; Kuster L; Csaicsich D; Gleiss A; Alper SL; Aufricht C; Vychytil A
PLoS One; 2016; 11(10):e0165045. PubMed ID: 27768727
[TBL] [Abstract][Full Text] [Related]
4. Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine.
Wiesenhofer FM; Herzog R; Boehm M; Wagner A; Unterwurzacher M; Kasper DC; Alper SL; Vychytil A; Aufricht C; Kratochwill K
Front Physiol; 2018; 9():1961. PubMed ID: 30719009
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses.
Herzog R; Bartosova M; Tarantino S; Wagner A; Unterwurzacher M; Sacnun JM; Lichtenauer AM; Kuster L; Schaefer B; Alper SL; Aufricht C; Schmitt CP; Kratochwill K
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33334074
[TBL] [Abstract][Full Text] [Related]
6. Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.
Bartosova M; Herzog R; Ridinger D; Levai E; Jenei H; Zhang C; González Mateo GT; Marinovic I; Hackert T; Bestvater F; Hausmann M; López Cabrera M; Kratochwill K; Zarogiannis SG; Schmitt CP
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32823646
[TBL] [Abstract][Full Text] [Related]
7. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
[TBL] [Abstract][Full Text] [Related]
8. Effects of different peritoneal dialysis fluids on the TH1/TH2 balance.
Libetta C; Esposito P; Sepe V; Guastoni C; Zucchi M; Meloni F; Dal Canton A
Eur Cytokine Netw; 2011 Mar; 22(1):24-31. PubMed ID: 21436014
[TBL] [Abstract][Full Text] [Related]
9. Effect of PD fluid instillation on the peritonitis-induced influx and bacterial clearing capacity of peritoneal cells.
Hekking LH; Huijsmans A; Van Gelderop E; Wieslander AP; Havenith CE; van den Born J; Beelen RH
Nephrol Dial Transplant; 2001 Mar; 16(3):679-82; idscussion 683-5. PubMed ID: 11239068
[TBL] [Abstract][Full Text] [Related]
10. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
11. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.
Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ
Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188
[TBL] [Abstract][Full Text] [Related]
12. Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures.
Herzog R; Boehm M; Unterwurzacher M; Wagner A; Parapatics K; Májek P; Mueller AC; Lichtenauer A; Bennett KL; Alper SL; Vychytil A; Aufricht C; Kratochwill K
Mol Cell Proteomics; 2018 Mar; 17(3):516-532. PubMed ID: 29208752
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes.
Parikova A; Hruba P; Krejcik Z; Stranecky V; Franekova J; Krediet RT; Viklicky O
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F229-F237. PubMed ID: 31760769
[TBL] [Abstract][Full Text] [Related]
14. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
16. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
17. Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model.
Sacnun JM; Hoogenboom R; Eibensteiner F; Sobieszek IJ; Unterwurzacher M; Wagner A; Herzog R; Kratochwill K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887356
[TBL] [Abstract][Full Text] [Related]
18. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
19. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
[TBL] [Abstract][Full Text] [Related]
20. Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.
Du C; Mendelson AA; Guan Q; Dairi G; Chafeeva I; da Roza G; Kizhakkedathu JN
J Transl Med; 2016 Dec; 14(1):338. PubMed ID: 27964722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
